Spotlight on HIV-derived TAT peptide as a molecular shuttle in drug delivery.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Spotlight on HIV-derived TAT peptide as a molecular shuttle in drug delivery.
- Published In:
- Drug discovery today, 29(11), 104191 (2024)
- Database ID:
- RPEP-08794
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08794APA
Maani, Zahra; Rahbarnia, Leila; Bahadori, Ali; Chollou, Khalil Maleki; Farajnia, Safar. (2024). Spotlight on HIV-derived TAT peptide as a molecular shuttle in drug delivery.. Drug discovery today, 29(11), 104191. https://doi.org/10.1016/j.drudis.2024.104191
MLA
Maani, Zahra, et al. "Spotlight on HIV-derived TAT peptide as a molecular shuttle in drug delivery.." Drug discovery today, 2024. https://doi.org/10.1016/j.drudis.2024.104191
RethinkPeptides
RethinkPeptides Research Database. "Spotlight on HIV-derived TAT peptide as a molecular shuttle ..." RPEP-08794. Retrieved from https://rethinkpeptides.com/research/maani-2024-spotlight-on-hivderived-tat
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.